Hong Kong Baptist University

Huawei Technologies Co., Limited

Hong Jie Zhang

Kaixian Chen

Zhaoxiang Bian

Aiping Lu

Dajian Yang

Albert Sun Chi Chan

Hongxi Xu

Shilin Chen

Yuanzhi Lao

Xiaoyu Wang

Kai Chen

Zhitang Chen

Yanhui Geng

Chengyuan Lin

Xin Li

Liang Feng Liu

Ju Xian Song

Hongsheng Tan

A coflow identification method includes: obtaining a weighted matrix by means of learning according to historical data in the network, where the weighted matrix is used to minimize a feature distance between data streams belonging to a same coflow and maximize a feature distance between data streams belonging to different coflows; computing a feature distance between any two data streams in the network according to metrics in the data stream layer data feature, the application layer data stream feature distance, the terminal aspect data feature distance, and the weighted matrix; and dividing the data streams in the network into several cluster sets by using a clustering algorithm and according to the feature distance between the any two data streams in the network, where each of the several cluster sets is a coflow.

Coflow identification method and system, and server using method

The present invention relates to a composition comprising compound of formula CB6 or CB8, the pharmaceutically-acceptable carrier, solvent, the salts thereof or a combination thereof which is used to treat autophagy-associated diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, etc. The present invention also relates to a method of treating these diseases by administering a therapeutically-effective amount of the compound to the subject in need of the treatment. The present invention further relates to the use of this compound in preparation of the composition to treat the diseases.

Synthesis of autophagy inducing compound and the uses thereof

Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I):  More particularly, it relates to said anti-prostate cancer compound that can be isolated fromor chemically synthesized and its specific anticancer/antitumor activity. The invention has a specific application in treating human prostate cancer.

Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer

Cervical cancer is one of the most common malignancies and is associated with a dismal prognosis. The most common therapeutic option for cervical cancer consists of surgery in early stages, and chemotherapy or radiotherapy in more advanced stages of the disease. Although treatment options have increased for some patients, overall progress has been modest. This invention relates to a method for treating cancer comprising administering an anti-cancer compound. More particularly, the present invention relates to an anti-cervical-cancer compound for treating human cervical cancer and tumor.

Anti-cervical cancer compound and method of use thereof

Growing community of inventors

Hong Kong, China

Hong Jie Zhang